MedTrace Logo

Magnesium Supplementation in Diabetic Nephropathy

NCT03824379 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-01-12

No results posted yet for this study

Summary

Higher prevalence of hypomagnesaemia in diabetic patients with nephropathy was compared to those without nephropathy. Serum magnesium levels were significantly inversely correlated with serum creatinine and U-A/C ratio, and positively correlated with glomerular filtration rate (GFR).

Hence, Magnesium supplementation using magnesium salts could be a good approach to improve the cardiovascular complications, insulin resistance index, lipid profile and kidney function in diabetic nephropathy patients.

Conditions

  • Diabetic Nephropathies

Interventions

DIETARY_SUPPLEMENT

Magnesium citrate

magnesium citrate equivalent 20-30 mmol elemental magnesium

DRUG

Antidiabetic

insulin or oral hypoglycemics

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Nihal Halawa · Faculty of Pharmacy - Ain Shams University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2020-03-01
Completion
2020-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03824379 on ClinicalTrials.gov